Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
MEDS

MEDS - Trxade Group Inc Stock Price, Fair Value and News

$0.50+0.02 (+4.17%)
Market Closed

80/100

MEDS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

80/100

MEDS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.8

Target 3M

$0.63

Target 6M

$0.72

MEDS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MEDS Price Action

Last 7 days

-3.8%

Last 30 days

-5.6%

Last 90 days

-67.5%

Trailing 12 Months

-87.9%

MEDS RSI Chart

MEDS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MEDS Valuation

Market Cap

20.3M

Price/Earnings (Trailing)

-0.99

Price/Sales (Trailing)

20.62

EV/EBITDA

-1.66

Price/Free Cashflow

-2.7

MEDS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.8

Target 3M

$0.63

Target 6M

$0.72

MEDS Fundamentals

MEDS Revenue

Revenue (TTM)

1.5M

Rev. Growth (Yr)

122.6%

Rev. Growth (Qtr)

76.45%

MEDS Earnings

Earnings (TTM)

-20.6M

Earnings Growth (Yr)

-13.31%

Earnings Growth (Qtr)

46.32%

MEDS Profitability

Operating Margin

99.84%

EBT Margin

-1421.42%

Return on Equity

-24.86%

Return on Assets

-19.61%

Free Cashflow Yield

-37.01%

MEDS Investor Care

Shares Dilution (1Y)

373.73%

Diluted EPS (TTM)

-9.88

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20250000
202401.1M1.3M1.5M
20237.5M6.5M4.5M875.1K
202210.1M11.5M11.3M10.3M
202118.0M13.3M9.5M9.9M
20208.1M12.8M16.8M17.1M
20194.5M5.6M7.0M7.4M
20183.1M3.2M3.3M3.8M
20172.8M2.9M3.0M3.0M
20162.4M2.7M3.0M3.2M
20151.9M2.8M4.1M2.1M
20141.1M1.2M1.4M1.5M
2013000955.9K
Get all data in R, Python etc through our Historical Stock Data APIs

About Trxade Group Inc

MEDS
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.
 CEO
 WEBSITEtrxadehealth.com
 SECTORHealthcare
 INDUSTRYPharmaceutical Retailers
 EMPLOYEES33

Trxade Group Inc Frequently Asked Questions

MEDS is the stock ticker symbol of Trxade Group Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jan 27 2026, market cap of Trxade Group Inc is 20.32 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check MEDS's fair value in chart for subscribers.

The fair value guage provides a quick view whether MEDS is over valued or under valued. Whether Trxade Group Inc is cheap or expensive depends on the assumptions which impact Trxade Group Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MEDS.

As of Tue Jan 27 2026, MEDS's PE ratio (Price to Earnings) is -0.99 and Price to Sales (PS) ratio is 20.62. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MEDS PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Trxade Group Inc has provided -0.411 (multiply by 100 for percentage) rate of return.